Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
CA 2025599 C · Owner: Fujisawa Pharmaceutical Co. Ltd. · Inventors: Konishi, Nobukiyo; Tsuji, Kiyoshi; Matsuo, Masaaki
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
There are described compounds of the, formula: (see formula I), wherein R1 is aryl which may be substituted with substituent(s) selected from the group consisting of lower alkyl, halogen, lower alkoxy, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl hydroxy, lower alkylsulfonyloxy, nitro amino, lower alkylamino, acylamino and lower alkyl(acyl)amino; or a heterocyclic group; R2 is hydrogen; methyl substituted with amino, lower aklylamino halogen or acyloxy; acyl; acylamino; cyano; halogen; lower alkylthio; lower alkylsufinyl; or a heterocyclic group; and R3 is aryl substituted with lower alkyl, lower alkylthio, lower alkylsulfinyl halogen, amino, lower alkylamino, acylamino lower, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 18, 1990 and granted November 20, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 18, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 18, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.